Manuela Cappelletti | Immunology | Industry Impact Award

Published on by Molecular Biologist

Mrs. Manuela Cappelletti | Immunology | Industry Impact Award 

Senior lab biologist | TAKIS srl | Italy

Mrs. Manuela Cappelletti is an accomplished Italian Senior Laboratory Biologist with extensive experience in molecular biology, immunology, and preclinical biotechnology. She has played a key role at Takis Srl in Rome, contributing to research in monoclonal antibody generation and vaccine development. Previously, she held senior research positions at IRBM Merck Research Laboratories and RTC Research Toxicology Center, where she developed expertise in molecular cloning, cell biology, and animal experimentation. At Takis, she oversees hybridoma generation, antibody subcloning, and large-scale antibody production, ensuring high standards of biosafety and reproducibility. Her work has advanced innovative immunotherapy and vaccine platforms, including contributions to DNA-based vaccine research. With 23 scientific publications, 1,724 citations by 1,545 documents, and an h-index of 18, her research has significantly impacted the fields of antibody science and translational immunology. Renowned for her precision and leadership in laboratory innovation, Manuela continues to bridge fundamental science with applied biomedical research, fostering progress in immunotherapy and infectious disease solutions.

Profile: Scopus | ORCID

Featured Publications

Cappelletti, M., et al. (n.d.). Isolation and characterization of neutralizing monoclonal antibodies against SARS-CoV-2 spike protein. Antibodies (Basel). Cited by 12.

Cappelletti, M., et al. (n.d.). COVID-eVax: An electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD. Molecular Therapy, 30(4). Cited by 58.

Cappelletti, M., et al. (n.d.). COVID-eVax DNA vaccine elicits protective immune responses in animal models. bioRxiv. Cited by 72.

Cappelletti, M., et al. (n.d.). Gene electro-transfer improves transduction by modifying the fate of intramuscular DNA. Journal of Gene Medicine, 5(3). Cited by 130.

Cappelletti, M., et al. (n.d.). C/EBP beta and acute phase gene regulation in liver cells. Cell Death and Differentiation, 3(2). Cited by 45.

 

FABIANA FOSCA FERRARA | Immunology | Best Industrial Research Award

Published on by Molecular Biologist

Dr. Fabiana Fosca | Immunology | Best Industrial Research Award 

Senior Researcher | Takis srl | Italy

Dr. Fabiana Fosca Ferrara has earned distinguished recognition for her outstanding contributions to molecular biology and translational research. She was honored with the Best Ph.D. Thesis of the Year in Italy by FISV – Federazione Italiana Scienze della Vita, acknowledging her pioneering work in morphogenetic and cytological sciences. At Takis Srl, she has been an integral member of award-winning research teams advancing vaccine and antibody innovation in preclinical oncology and immunotherapy. Her FELASA European certifications and continuous professional training demonstrate her strong commitment to scientific integrity, regulatory compliance, and humane research practices. Dr. Ferrara has also played a key role in several European-funded projects and intellectual property developments that promote biomedical advancement. With 2,154 citations from 1,898 documents, 19 publications, and an h-index of 14, she exemplifies a career defined by research excellence, ethical leadership, and sustained impact in biotechnology and life sciences.

Profile: Scopus| ORCID

Featured Publications

Ferrara, F. F., et al. “Novel humanized anti-HER3 antibodies: Structural characterization and therapeutic activity.” Antibodies. – Cited by 12.

Ferrara, F. F., et al. “Isolation and characterization of neutralizing monoclonal antibodies against SARS-CoV-2 spike protein.” Antibodies. – Cited by 25.

Ferrara, F. F., et al. “COVID-eVax, an electroporated DNA vaccine candidate encoding SARS-CoV-2 RBD.” Molecular Therapy. – Cited by 180.

Ferrara, F. F., et al. “Novel benzazole derivatives endowed with potent antiheparanase activity.” Journal of Medicinal Chemistry. – Cited by 92.

Ferrara, F. F., et al. “Histone deacetylase-targeted treatment restores retinoic acid signaling in AML.” Cancer Research. – Cited by 550.